Proposed Legislation Seeks to Authorize AI as Drug Prescribers
Proposed legislation seeks to authorize AI as a legal prescriber of medication, sparking debate over regulatory readiness, patient safety, and the future…

New federal legislation has been introduced in the U.S. House of Representatives that would amend the Federal Food, Drug, and Cosmetic Act to classify artificial intelligence and machine learning technologies as practitioners eligible to prescribe medications. The bill, currently under review by the House Committee on Energy and Commerce, requires that such AI systems receive FDA approval and authorization from individual states to function in a prescribing capacity.
The proposal aims to address systemic healthcare gaps and reduce administrative burdens on medical professionals. Proponents argue that integrating AI into clinical workflows could improve diagnostic accuracy, increase patient adherence to medication, and lower government healthcare expenditures by streamlining medical operations.
Federal Food
However, medical experts have raised significant concerns regarding the current maturity of the technology and the lack of specific regulatory frameworks within the bill. Critics note that the legislation does not define which classes of drugs would be eligible for AI-led prescriptions, nor does it clarify whether human physician oversight would be a mandatory requirement for high-risk medications.
Industry observers suggest that if such technology is to be deployed, it will likely face a high regulatory threshold similar to that of autonomous vehicles. While some experts acknowledge the potential for AI to augment clinical decision-making, professional medical organizations maintain that these tools should serve to complement, rather than replace, the judgment of human clinicians.
This legislative effort follows a previous, unsuccessful attempt to introduce similar measures in 2023. The bill's progress remains uncertain as policymakers continue to balance the rapid advancement of medical technology against the need for patient safety and institutional accountability in healthcare delivery.
More stories
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Congress tests Black Democrats' growing policy influence
- Cotton faults Lutnick over AI chips allegedly sent to China
- Vance declines to back Iran strikes as Trump defends war
- Paul seeks 20%-30% federal credit for U.S. film shoots
- Trump targets data centers abroad with tax threat to firms
- T-Mobile agrees to drop 50 GB cap in New York broadband deal
- Iran threats put Bessent security alongside sanctions push
- Kansas puts Senate control within Democrats' wider reach
- Byron Donalds faces tighter Florida contest over Trump ties
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Baltic responders fight Sparta II fire after drone strike
- Dietitians advise small swaps for plant-based eating
- Europe faces attribution gap after 16 cyber, physical incidents

